AACT Polyclonal Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.
Synonyms
ACT; AACT; GIG24; GIG25; Alpha-1-antichymotrypsin; Cell growth-inhibiting gene 24/25 protein; Serpin A3; SERPINA3
Gene ID
12
Swiss Prot
P01011
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
121-320/423
Target
AACT
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human AACT-Alpha1
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
12
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
240975-01 1 g
Nw- (2,2,4,6,7-Pentamethyldihydrobenzofuran-5-sulfonyl) -L-arginine 99+% (HPLC)
Ask
View Details 240975-02 5 g
Nw- (2,2,4,6,7-Pentamethyldihydrobenzofuran-5-sulfonyl) -L-arginine 99+% (HPLC)
Ask
View Details 240975-03 25 g
Nw- (2,2,4,6,7-Pentamethyldihydrobenzofuran-5-sulfonyl) -L-arginine 99+% (HPLC)
Ask
View Details